Scientific article

Prise en charge chirurgicale de l’hidradénite suppurée

Published inRevue médicale suisse, vol. 19, no. 820, p. 624-629
Publication date2023-03-29

Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease that primarily affects the apocrine skin glands. Management options include risk factor modification, pharmacologic agents, and surgery. Many surgical management techniques exist, including incision and drainage, laser hair removal, deroofing, limited or wide local excision. Deroofing is an interesting alternative for simple superficial fistulas and potentially even for more complex lesions. Surgical treatment can be combined with drug treatment. The indication depends on a comprehensive and multidisciplinary assessment considering the severity and number of target lesions.

  • Humans
  • Hidradenitis Suppurativa / surgery
  • Drainage / methods
  • Chronic Disease
Citation (ISO format)
PASTOR, Damien et al. Prise en charge chirurgicale de l’hidradénite suppurée. In: Revue médicale suisse, 2023, vol. 19, n° 820, p. 624–629. doi: 10.53738/REVMED.2023.19.820.624
Main files (1)
Article (Published version)
accessLevelRestrictedaccessLevelPublic 09/30/2024
ISSN of the journal1660-9379

Technical informations

Creation12/20/2023 3:04:03 PM
First validation04/08/2024 8:07:19 AM
Update time04/08/2024 8:07:19 AM
Status update04/08/2024 8:07:19 AM
Last indexation05/06/2024 6:20:21 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack